Inhibiting a Key Enzyme Reduces Cancer Cell Survival
Author Information
Author(s): Sekhon J, Pereira P, Sabbaghian N, Schievella A R, Rozen R
Primary Institution: McGill University Health Centre
Hypothesis
Methylenetetrahydrofolate reductase inhibition would affect cell viability through decreased methionine synthesis.
Conclusion
Inhibiting methylenetetrahydrofolate reductase significantly reduces the survival of methionine-dependent tumor cells.
Supporting Evidence
- Inhibition of methylenetetrahydrofolate reductase led to an 80% decrease in survival of colon carcinoma cells.
- Transformed cell lines showed significantly reduced survival in methionine-deficient media.
- Normal fibroblasts maintained growth in methionine-deficient conditions, unlike transformed cells.
Takeaway
This study found that blocking a specific enzyme can make cancer cells die faster, while normal cells are not affected.
Methodology
The study used antisense oligonucleotides to inhibit methylenetetrahydrofolate reductase in various cancer cell lines and measured cell survival.
Potential Biases
Potential bias due to the use of specific cell lines and the controlled laboratory environment.
Limitations
The study was conducted in vitro, and results may not directly translate to in vivo conditions.
Participant Demographics
The study involved transformed human cancer cell lines and nontransformed human fibroblasts.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website